» Articles » PMID: 23786927

Spectrum and Antimicrobial Resistance of Common Pathogenic Bacteria Isolated from Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Mainland of China

Overview
Specialty General Medicine
Date 2013 Jun 22
PMID 23786927
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Bacteria-induced respiratory infection has been long considered to be the major cause of acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Therefore, a clear picture about the distribution and drug-resistance of pathogenic bacteria in the lower airways should be helpful for treatment of the disease. So far, data on this topic among Chinese are lacking.

Methods: A surveillance study was performed in consecutive patients with AECOPD at five areas in China between October 2006 and April 2008. The sputum from these patients was cultured and isolated for bacteria. Agar dilution method was used to determine the minimal inhibitory concentrations (MICs) of levofoxacin and other 15 antibiotics against these strains.

Results: Three hundred and fifty-nine pathogenic bacterial strains were isolated among 884 patients with AECOPD. The predominant bacteria were Pseudomonas aeruginosa (21.7%), Klebsiella pneumoniae (12.3%), Haemophilus influenzae (14.2%) and Streptococcus pneumoniae (11.7%), followed by Haemophilus parainfluenzae (9.5%), Acinetobacter baumannii (7.8%), Moraxella catarrhalis (6.4%) and Escherichia coli (3.6%). The majority of bacterial pathogens isolated in this study were susceptible to fuoroquinolones, ceftazidime, cefepime and imipenem.

Conclusions: Gram-negative bacilli are the leading pathogens in patients with AECOPD in China. Haemophilus parainfluenzae may be one of the most important pathogens in AECOPD. This study provides evidence for local surveillance of AECOPD pathogens and appropriate choice of antimicrobials in China.

Citing Articles

Spectrum and antimicrobial resistance in acute exacerbation of chronic obstructive pulmonary disease with pneumonia: a cross-sectional prospective study from Vietnam.

Dao D, Le H, Nguyen M, Thi T, Nguyen X, Bui T BMC Infect Dis. 2024; 24(1):622.

PMID: 38910264 PMC: 11194910. DOI: 10.1186/s12879-024-09515-6.


Exploring the impact of OSA on short-term survival in patients with AECOPD admitted to the ICU.

Liu L, Chen Y, He G, Lin B, Zhu Z, Wei R PLoS One. 2024; 19(4):e0301646.

PMID: 38603665 PMC: 11008870. DOI: 10.1371/journal.pone.0301646.


Analyses of Factors Associated with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Review.

Qian Y, Cai C, Sun M, Lv D, Zhao Y Int J Chron Obstruct Pulmon Dis. 2023; 18:2707-2723.

PMID: 38034468 PMC: 10683659. DOI: 10.2147/COPD.S433183.


Identification of microbial markers associated with lung cancer based on multi-cohort 16 s rRNA analyses: A systematic review and meta-analysis.

Han W, Wang N, Han M, Liu X, Sun T, Xu J Cancer Med. 2023; 12(18):19301-19319.

PMID: 37676050 PMC: 10557844. DOI: 10.1002/cam4.6503.


Airway pathogens detected in stable and exacerbated COPD in patients in Asia-Pacific.

Taddei L, Malvisi L, Hui D, Malvaux L, Samoro R, Lee S ERJ Open Res. 2022; 8(3).

PMID: 36171985 PMC: 9511156. DOI: 10.1183/23120541.00057-2022.